Authors:
Ezzet, F
Krishna, G
Wexler, DB
Statkevich, P
Kosoglou, T
Batra, VK
Citation: F. Ezzet et al., A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe, CLIN THER, 23(6), 2001, pp. 871-885
Authors:
Jen, JF
Glue, P
Ezzet, F
Chung, C
Gupta, SK
Jacobs, S
Hajian, G
Citation: Jf. Jen et al., Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C, CLIN PHARM, 69(6), 2001, pp. 407-421
Authors:
Ezzet, F
van Vugt, M
Nosten, F
Looareesuwan, S
White, NJ
Citation: F. Ezzet et al., Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria, ANTIM AG CH, 44(3), 2000, pp. 697-704
Authors:
Bindschedler, M
Lefevre, G
Ezzet, F
Schaeffer, N
Meyer, I
Thomsen, MS
Citation: M. Bindschedler et al., Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers, EUR J CL PH, 56(5), 2000, pp. 375-381
Authors:
van Vugt, M
Ezzet, F
Nosten, F
Gathmann, I
Wilairatana, P
Looareesuwan, S
White, NJ
Citation: M. Van Vugt et al., No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine, AM J TROP M, 61(6), 1999, pp. 964-967
Citation: F. Ezzet et al., Population pharmacokinetics and therapeutic response of CGP56697 (artemether plus benflumetol) in malaria patients, BR J CL PH, 46(6), 1998, pp. 553-561